I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
February 03, 2020 14:11 ET
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
June 17, 2019 11:05 ET
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
April 01, 2019 10:22 ET
|
I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
March 26, 2019 13:42 ET
|
I-MED Pharma
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with...
Visiongain report says: Global Ophthalmic Drugs Market Set To Grow To $29bn By 2022
December 12, 2018 07:48 ET
|
Visiongain Ltd
LONDON, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Visiongain report says: Global Ophthalmic Drugs Market Set To Grow To $29bn By 2022. Visiongain has launched a new pharma report entitled Global...
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
May 24, 2018 13:36 ET
|
I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
May 24, 2018 13:36 ET
|
I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications
March 21, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has retained the...
Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease
July 26, 2016 07:59 ET
|
Parion Sciences
DURHAM, N.C,, July 26, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today it has initiated a...
Ceva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface Diseases
January 19, 2016 08:00 ET
|
Parion Sciences
LIBOURNE, France and DURHAM, N.C., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Ceva Santé Animale and Zoion Pharma Inc. announced today that they have entered into a collaboration to develop an epithelial...